Observational Studies 2015 - Conducting Observational Studies in US, Canada and Europe
Date2015-06-07
Deadline2015-06-07
VenueOnline event, USA - United States
KeywordsObservational Studies in US; Observational Studies in europ; Observational Studies in CA
Websitehttps://bit.ly/1auvreL
Topics/Call fo Papers
Overview:
This presentation will clarify the confusion and illuminate the various requirements across the United States, Europe and Canada.
Some guidelines have been developed and others are in the process of being developed. In some jurisdictions clinical trials are differentiated from observational studies. Conducting such studies retrospectively or prospectively can have a different requirement from a regulatory perspective. The same study done in different jurisdictions will follow different regulatory pathways. Working through this confusing environment is very difficult.
Areas Covered in the Session:
What observational studies are and when they are used, including actual examples of such studies conducted in the United States, Canada and Europe.
When retrospective observational studies are useful and when prospective observational studies are done.
The difference between observational studies and registries.
Existing guidelines on such studies in the various jurisdictions.
Regulatory requirements to conduct such studies in a jurisdiction.
Multi-center studies conducted across jurisdictions.
When payer databases are useful and when other approaches are used.
Reporting adverse events in observational studies.
Compliance4All
Adam Fleaming
Phone: +1-800-447-9407
Event Link: http://bit.ly/1auvreL
support-AT-compliance4all.com
www.compliance4all.com
This presentation will clarify the confusion and illuminate the various requirements across the United States, Europe and Canada.
Some guidelines have been developed and others are in the process of being developed. In some jurisdictions clinical trials are differentiated from observational studies. Conducting such studies retrospectively or prospectively can have a different requirement from a regulatory perspective. The same study done in different jurisdictions will follow different regulatory pathways. Working through this confusing environment is very difficult.
Areas Covered in the Session:
What observational studies are and when they are used, including actual examples of such studies conducted in the United States, Canada and Europe.
When retrospective observational studies are useful and when prospective observational studies are done.
The difference between observational studies and registries.
Existing guidelines on such studies in the various jurisdictions.
Regulatory requirements to conduct such studies in a jurisdiction.
Multi-center studies conducted across jurisdictions.
When payer databases are useful and when other approaches are used.
Reporting adverse events in observational studies.
Compliance4All
Adam Fleaming
Phone: +1-800-447-9407
Event Link: http://bit.ly/1auvreL
support-AT-compliance4all.com
www.compliance4all.com
Other CFPs
- How to Respond to an FDA Investigation: What happens when the FDA threatens to shut you
- Supplier Quality Management - Implement it Now or Pay for it Later
- Using the ISP98 Model Forms for Standby Letters of Credit
- THEIIER-7th International Conference on Recent Advances in Medical Science (ICRAMS-2015)
- THEIIER-8th International Conference on Social Science and Economics(ICSSE-2015)
Last modified: 2015-04-15 18:48:57